Skip to main content
Premium Trial:

Request an Annual Quote

Devyser Signs Chinese Distribution Deal for Prenatal Aneuploidy Tests

NEW YORK (GenomeWeb) – Swedish diagnostic company Devyser has signed a distribution deal for its rapid prenatal aneuploidy diagnostic test kits in China with Dahui Biotech, the companies announced today.

Specific terms of the deal were not disclosed.

"There is an increasing demand for our prenatal diagnostic products in China," Devyser Founding Partner and CEO Ulf Klangby said in a statement. "Dahui Biotech's established distribution and service organization reaches genetic laboratories across China."

Devyser offers a range of PCR-based tests including Compact QF-PCR, which enables prenatal aneuploidy analysis of chromosomes 13, 18, 21, and XY; Extend QF-PCR for pregnancy loss aneuploidy analysis covering chromosomes 13, 15, 16, 18, 21, 22, and XY; and Complete QF-PCR for rapid aneuploidy analysis of chromosomes 13, 18, 21, and XY.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.